Lemaitre Vascular Inc 63 Second Avenueburlington Ma 01803 Pma Numbern16837 Supplement Numbers028 Date Received09 16 2022 Decision Date10 14 2022 Product Code Lxa Advisory Committee Cardiovascular Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Lemaitre Vascular Inc 63 Second Avenueburlington Ma 01803 Pma Numbern16837 Supplement Numbers028 Date Received09 16 2022 Decision Date10 14 2022 Product Code Lxa Advisory Committee Cardiovascular Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA N16837S028 LeMaitre Vascular, Inc.63 Second Avenueburlington, MA 01803 PMA NumberN16837 Supplement NumberS028 Date Received09/16/2022 Decision Date10/14/2022 Product Code LXA  Advisory Committee Cardiovascular Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	Artegraft Collagen Vascular Graft	2022-10-14